Annual Operating Margin
-1862.69%
-727.93%-64.15%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual operating profit margin is -1862.69%, with the most recent change of -727.93% (-64.15%) on December 31, 2023.
- During the last 3 years, CYTH annual operating margin has fallen by -870.84% (-87.80%).
- CYTH annual operating margin is now -5030.36% below its all-time high of 37.78%, reached on December 31, 2002.
Performance
CYTH Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-3545.95%
+1032.04%+22.54%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly operating profit margin is -3545.95%, with the most recent change of +1032.04% (+22.54%) on September 30, 2024.
- Over the past year, CYTH quarterly operating margin has dropped by -1733.96% (-95.69%).
- CYTH quarterly operating margin is now -5482.44% below its all-time high of 65.88%, reached on December 31, 2006.
Performance
CYTH Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
CYTH Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.2% | -95.7% |
| 3 y3 years | -87.8% | -95.7% |
| 5 y5 years | -342.8% | -95.7% |
CYTH Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -107.0% | at low | -648.6% | +22.5% |
| 5 y | 5-year | -153.8% | at low | -648.6% | +22.5% |
| alltime | all time | -5030.4% | at low | -5482.4% | +22.5% |
Cyclo Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -3545.95%(-22.5%) |
| Jun 2024 | - | -4577.99%(+81.4%) |
| Mar 2024 | - | -2523.71%(+39.3%) |
| Dec 2023 | -1862.69%(+64.1%) | -1811.99%(+88.3%) |
| Sep 2023 | - | -962.20%(-75.7%) |
| Jun 2023 | - | -3955.79%(+20.4%) |
| Mar 2023 | - | -3285.28%(+23.4%) |
| Dec 2022 | -1134.76%(+26.1%) | -2661.97%(+183.3%) |
| Sep 2022 | - | -939.59%(+47.3%) |
| Jun 2022 | - | -637.78%(-57.6%) |
| Mar 2022 | - | -1505.59%(+217.9%) |
| Dec 2021 | -899.77%(-9.3%) | -473.65%(-50.4%) |
| Sep 2021 | - | -955.40%(-36.7%) |
| Jun 2021 | - | -1509.05%(+33.9%) |
| Mar 2021 | - | -1127.31%(-38.8%) |
| Dec 2020 | -991.85%(+35.2%) | -1841.84%(+185.3%) |
| Sep 2020 | - | -645.50%(-38.5%) |
| Jun 2020 | - | -1049.95%(+29.4%) |
| Mar 2020 | - | -811.10%(-25.8%) |
| Dec 2019 | -733.80%(+74.4%) | -1092.57%(+91.8%) |
| Sep 2019 | - | -569.62%(+13.5%) |
| Jun 2019 | - | -501.76%(-41.9%) |
| Mar 2019 | - | -863.93%(+52.6%) |
| Dec 2018 | -420.64%(+35.6%) | -566.06%(+60.9%) |
| Sep 2018 | - | -351.81%(-5.1%) |
| Jun 2018 | - | -370.55%(-9.9%) |
| Mar 2018 | - | -411.16%(-49.8%) |
| Dec 2017 | -310.29%(+39.5%) | -819.82%(+210.4%) |
| Sep 2017 | - | -264.11%(+66.3%) |
| Jun 2017 | - | -158.84%(-51.6%) |
| Mar 2017 | - | -328.38%(+122.4%) |
| Dec 2016 | -222.38%(-6.7%) | -147.63%(-48.7%) |
| Sep 2016 | - | -287.83%(+3.6%) |
| Jun 2016 | - | -277.70%(+19.2%) |
| Mar 2016 | - | -233.00%(-58.7%) |
| Dec 2015 | -238.35%(+564.5%) | -563.72%(+115.0%) |
| Sep 2015 | - | -262.16%(+183.0%) |
| Jun 2015 | - | -92.64%(-58.1%) |
| Mar 2015 | - | -221.27%(+218.4%) |
| Dec 2014 | -35.87%(-241.2%) | -69.49%(+36.2%) |
| Sep 2014 | - | -51.01%(-58.4%) |
| Jun 2014 | - | -122.67%(-534.4%) |
| Mar 2014 | - | 28.24%(-649.4%) |
| Dec 2013 | 25.40%(+52.2%) | -5.14%(-91.7%) |
| Sep 2013 | - | -61.58%(-218.3%) |
| Jun 2013 | - | 52.04%(+72.0%) |
| Mar 2013 | - | 30.25%(-51.6%) |
| Dec 2012 | 16.69% | 62.52%(-443.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -18.19%(-54.5%) |
| Jun 2012 | - | -40.01%(-331.7%) |
| Mar 2012 | - | 17.27%(-147.4%) |
| Dec 2011 | -7.20%(+386.5%) | -36.41%(+82.3%) |
| Sep 2011 | - | -19.97%(-280.9%) |
| Jun 2011 | - | 11.04%(-734.5%) |
| Mar 2011 | - | -1.74%(-106.9%) |
| Dec 2010 | -1.48%(-95.4%) | 25.22%(-450.8%) |
| Sep 2010 | - | -7.19%(-143.6%) |
| Jun 2010 | - | 16.48%(-128.0%) |
| Mar 2010 | - | -58.81%(-41.4%) |
| Dec 2009 | -32.21%(+8.2%) | -100.35%(-821.4%) |
| Sep 2009 | - | 13.91%(-240.4%) |
| Jun 2009 | - | -9.91%(-78.0%) |
| Mar 2009 | - | -45.13%(+65.9%) |
| Dec 2008 | -29.76%(-215.4%) | -27.20%(+365.8%) |
| Sep 2008 | - | -5.84%(-50.0%) |
| Jun 2008 | - | -11.67%(-90.8%) |
| Mar 2008 | - | -126.49%(-598.6%) |
| Dec 2007 | 25.78%(+110.4%) | 25.37%(-10.3%) |
| Sep 2007 | - | 28.28%(-38.3%) |
| Jun 2007 | - | 45.80%(-3916.7%) |
| Mar 2007 | - | -1.20%(-101.8%) |
| Dec 2006 | 12.25%(-149.4%) | 65.88%(-299.2%) |
| Sep 2006 | - | -33.08%(+221.5%) |
| Jun 2006 | - | -10.29%(-161.5%) |
| Mar 2006 | - | 16.74%(-125.4%) |
| Dec 2005 | -24.79%(-58.7%) | -65.83%(+6.0%) |
| Sep 2005 | - | -62.10%(-542.3%) |
| Jun 2005 | - | 14.04%(-482.6%) |
| Mar 2005 | - | -3.67%(-107.2%) |
| Dec 2004 | -60.02%(-479.6%) | 50.82%(+945.7%) |
| Sep 2004 | - | 4.86%(-53.2%) |
| Jun 2004 | - | 10.39%(-153.4%) |
| Mar 2004 | - | -19.44%(-367.4%) |
| Dec 2003 | 15.81%(-58.2%) | 7.27%(-80.1%) |
| Sep 2003 | - | 36.48%(+28.0%) |
| Jun 2003 | - | 28.50%(-318.2%) |
| Mar 2003 | - | -13.06%(-71.4%) |
| Dec 2002 | 37.78%(-561.3%) | -45.67%(-179.6%) |
| Sep 2002 | - | 57.37%(+55.1%) |
| Jun 2002 | - | 36.98%(-25.6%) |
| Mar 2002 | - | 49.70%(-228.7%) |
| Dec 2001 | -8.19%(-69.2%) | -38.62%(+27.7%) |
| Sep 2001 | - | -30.25%(-276.0%) |
| Jun 2001 | - | 17.19%(+809.5%) |
| Mar 2001 | - | 1.89%(-101.1%) |
| Dec 2000 | -26.62% | -167.95%(+741.4%) |
| Sep 2000 | - | -19.96% |
FAQ
- What is Cyclo Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual operating margin year-on-year change?
- What is Cyclo Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly operating margin year-on-year change?
What is Cyclo Therapeutics annual operating profit margin?
The current annual operating margin of CYTH is -1862.69%
What is the all time high annual operating margin for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual operating profit margin is 37.78%
What is Cyclo Therapeutics annual operating margin year-on-year change?
Over the past year, CYTH annual operating profit margin has changed by -727.93% (-64.15%)
What is Cyclo Therapeutics quarterly operating profit margin?
The current quarterly operating margin of CYTH is -3545.95%
What is the all time high quarterly operating margin for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly operating profit margin is 65.88%
What is Cyclo Therapeutics quarterly operating margin year-on-year change?
Over the past year, CYTH quarterly operating profit margin has changed by -1733.96% (-95.69%)